Summary
The Cholesterol is an essential component for biological membranes and is a precursor of a steroid hormone. Thus, cholesterol metabolism is strictly regulated by en zyme reactions and gene expression, resulting in nor mal cholesterol homeostasis. The disturbance of the cholesterol homeostatic mechanism due to high choles terol intake ultimately provokes elevation of the serum cholesterol levels, thus being involved in the develop ment of coronary heart diseases (1) and atherosclerosis (2) . It is therefore very important to lower the serum cholesterol concentration to prevent these diseases.
Tsuji et al. (3) found that serum and liver cholesterol concentrations were lowered by the intake of taurine in rats fed cholesterol-enriched diets. Many works have been devoted to studying the effect of dietary taurine on serum cholesterol concentration in animals fed a high cholesterol diet, and the hypocholesterolemic effect of taurine feeding has been identified (4-6). We have also observed the hypocholesterolemic effect of taurine in hypercholesterolemic rats induced by dietary choles terol (7) and other factors such as diabetes mellitus, hy pothyroid, and xenobiotics (8-10). In addition, taurine feeding increases the fecal excretion of bile acids accom panied by the induction of cholesterol 7a-hydroxylase (CYP7A1) activity and its gene expression (7) . On the other hand, taurine itself did not induce hepatic CYP7A1 gene expression when incubated in primary rat-cultured hepatocytes (our unpublished data). Thus, the induction of CYP7A1 by dietary taurine is a second ary effect to the gene expression of CYP7A1.
The induction of hepatic CYP7A1 by taurine intake may be mediated through the increased secretion of bile acid because taurine plays a role in the conjugation of bile acid. Increased bile acid secretion results in expan sion of the intestinal pool of bile acid and increased ac tivity of hepatic CYP7A1 (11). Hepatic CYP7A1 is also affected by the variation of bile acid pool size in the in testine (12). There have been no studies to examine the hypocholesterolemic effect of taurine in rats whose in testinal pool of bile acid was altered. In the present study, we examined the effect of taurine on serum cho lesterol concentration and hepatic CYP 7A1 activity when rats were fed cholestyramine and a high amount of sodium cholate. Cholestyramine feeding increases the intestinal pool and fecal excretion of bile acids due to the inhibition of bile acid absorption from the ileum, whereas high bile acid feeding elevated them owing to the overflow of unabsorbed dietary bile acid. Pandak et al. reported that hepatic CYP7A1 activity rose 200% in rats fed a 5% cholestyramine diet, while a 1% sodium cholate diet decreased activity by 38% as compared to respective controls (13). Metheson et al, also demon strated a similar observation in rats fed a 2% cholestyramine diet (14). activity by 3 8 % as compared to controls (13). There fore, the negative feedback regulation of CYP7A1 by bile acid may occur only in rats fed a cholesterol-free diet. Therefore, it is presumed that, in the present study, the different response of high bile acid feeding on CYP7A1 activity resulted from the coexistence of a posi tive factor (cholesterol) and a negative factor (sodium cholate) in the diets.
In the present study, the diet conditions were conse quently complex. However, it is apparent that CYP7A1 is induced by taurine intake, which then reduces serum cholesterol. Therefore, it appears that the degradation of cholesterol into bile acids plays an important role in the effect of taurine. In summary, it is suggested that taurine induces the catabolism of cholesterol to bile acids through hepatic CYP7A1 activity, even though the bile acid pool size is increased by the administration of exogenous bile acid, resulting in the reduction of serum cholesterol. Moreover, the mechanism of hypoc holesterolemic effect due to taurine may be similar to that due to cholestyramine. 
